ArticleFrontiers in medicine2025
Rheumatoid arthritis and chronic obstructive pulmonary disease in US adults: a cross-sectional analysis.
Article in Frontiers in medicine, 2025. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Cited by 1 paper.
What it found
Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.
The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.
The trial behind it
Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.
Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.
Who cites it
1 citing paper in PubMed.
- Methodological Concerns Regarding the Causal Relationship Between Methotrexate and COPD: The Missing Confounding by Indication [Letter].International journal of chronic obstructive pulmonary disease · 2026Article
Corrections and comments
PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.
Authors and funding
7 authors.
Funding
No grant is acknowledged in the PubMed record.
Abstract
Background: Globally, chronic obstructive pulmonary disease (COPD) has emerged as one of the most prevalent chronic respiratory disorders, imposing substantial healthcare challenges and contributing significantly to premature mortality. Emerging evidence indicates that chronic inflammation and immune responses play crucial roles in the pathogenesis and progression of COPD. Rheumatoid arthritis (RA) is a chronic immune-mediated multisystem disease, but its association with COPD remains inconsistent. The primary objective of this investigation is to assess the potential association between RA and COPD. Methods: Data were derived from the National Health and Nutrition Examination Survey from 2007 to March 2020, which encompassed 25,682 participants. Multivariable logistic regression models were employed to assess the relationship between RA and COPD. To comprehensively evaluate the association's robustness, we conducted subgroup analyses along with sensitivity analyses, examining potential confounding factors and effect modifiers. Results: RA was associated with a higher prevalence of COPD even after adjusting for demographic, socioeconomic, lifestyle, and health-related factors (adjusted OR = 1.52, 95% CI: 1.23-1.87, Conclusion: RA is significantly associated with COPD in US adults, highlighting the importance of early detection and preventive strategies aimed at mitigating COPD risk in patients with RA.
Indexed as
Identifiers
What Socratic holds
Registered trials
Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the Socratic graph.